Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

TRANSLUX CL

K-Number: K843823 · 1984-12-04

ApplicantKulzer, Inc.
Decision Date1984-12-04
Product CodeEBZ
Advisory CommitteeDE
DecisionSubstantially Equivalent

Device Summary

TRANSLUX CL is the device name listed in this FDA 510(k) record. The listed applicant is Kulzer, Inc.. It received FDA 510(k) clearance on 1984-12-04 under 510(k) number K843823. The device is classified under product code EBZ. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the TRANSLUX CL?

TRANSLUX CL is a medical device that received FDA 510(k) clearance on 1984-12-04. The listed applicant is Kulzer, Inc.. The 510(k) number is K843823.

When did TRANSLUX CL receive FDA 510(k) clearance?

TRANSLUX CL received FDA 510(k) clearance on 1984-12-04, under 510(k) number K843823.

Who is the listed applicant for TRANSLUX CL?

The FDA 510(k) record lists Kulzer, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for TRANSLUX CL?

The FDA product code for TRANSLUX CL is EBZ.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Other records listing Kulzer, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 31 devices →

Related Devices (Code: EBZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑